Clinical study offer

🦋 Paid Lupus Clinical Trials

Browse recruiting lupus clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Lupus
Condition

Active Clinical Trials for Lupus

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Lupus

Lupus (systemic lupus erythematosus) is a chronic autoimmune disease where the immune system attacks healthy tissues affecting multiple organs. Clinical trials investigate biologic therapies, targeted immunomodulators, and approaches to reduce disease flares.

Common Symptoms

Butterfly-shaped facial rash, joint pain and swelling, fatigue, fever, chest pain, kidney problems, photosensitivity, hair loss, mouth ulcers

Risk Factors

Female gender, age (15-45), family history, certain ethnicities (African American, Hispanic, Asian), certain medications, Epstein-Barr virus, sunlight exposure

Treatment Overview

Treatment includes NSAIDs, antimalarials (hydroxychloroquine), corticosteroids, immunosuppressants, and biologic therapies (belimumab). Clinical trials explore novel B-cell targeting agents, interferon pathway inhibitors, and CAR T-cell therapy for lupus.

Why Participate?

Lupus clinical trials advance treatment options for this complex autoimmune disease with limited therapeutic options, especially for severe organ involvement.

Related Conditions

States with Lupus Clinical Trials

Cities with Lupus Clinical Trials

Frequently Asked Questions About Lupus Clinical Trials

Lupus clinical trials test new medications and immunotherapies to reduce autoimmune activity and prevent organ damage. Studies aim to reduce disease flares and steroid dependence.
Eligibility depends on lupus type and severity, organ involvement, disease activity level, and prior treatments. Some studies focus on lupus nephritis or cutaneous lupus.
Compensation varies. Participants may receive $50-$200 per visit with study medications and monitoring provided at no cost.
Yes, participants receive regular monitoring including blood tests and organ function assessments. All trials have independent safety oversight.